Search research articles
Contact Us
Filters
Showing results (431-440 of 545) with videos related to
Page
of 55
Sort By:
Plos Pathogens
|
September 13, 2008
Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes
Paul D Cotter, Lorraine A Draper, Elaine M Lawton, et al.
Current Opinion in Biotechnology
|
November 21, 2017
Identification of probiotic effector molecules: present state and future perspectives
Sarah Lebeer, Peter A Bron, Maria L Marco, et al.
World Journal of Gastrointestinal Pathophysiology
|
September 20, 2023
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against <i>Clostridioides difficile</i> infection challenge <i>in vivo</i>
Christopher K Murphy, Michelle M O'Donnell, James W Hegarty, et al.
Frontiers in Microbiology
|
October 12, 2017
Development of a Click Beetle Luciferase Reporter System for Enhanced Bioluminescence Imaging of <i>Listeria monocytogenes</i>: Analysis in Cell Culture and Murine Infection Models
Sadeeq Ur Rahman, Michael Stanton, Pat G Casey, et al.
The Journal of Dairy Research
|
May 19, 2009
Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1beta and IL-8 gene expression
Christine Beecher, Mairéad Daly, Donagh P Berry, et al.
Radiation Oncology (London, England)
|
July 18, 2018
High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events
Kara D Romano, Colin Hill, Daniel M Trifiletti, et al.
The British Journal of Nutrition
|
July 9, 2011
Probiotic and prebiotic claims in Europe: seeking a clear roadmap
Francisco Guarner, Mary Ellen Sanders, Glenn Gibson, et al.
Current Opinion in Biotechnology
|
October 9, 2018
Understanding mode of action can drive the translational pipeline towards more reliable health benefits for probiotics
Michiel Kleerebezem, Sylvie Binda, Peter A Bron, et al.
Gut Microbes
|
March 30, 2023
Temperate bacteriophages infecting the mucin-degrading bacterium <i>Ruminococcus gnavus</i> from the human gut
Colin Buttimer, Ekaterina V Khokhlova, Lisa Stein, et al.
Applied Microbiology and Biotechnology
|
February 26, 2026
Evaluation of the delivery of an anti-Listeria endolysin via CRISPR-Cas9 engineered probiotic Saccharomyces boulardii
David Sáez Moreno, João Paulo Carvalho, Ellen Murray, et al.
Page
of 55
Search research articles
Search
Showing results (431-440 of 545) with videos related to
Sort By:
Page
of 55
Plos Pathogens
|
September 13, 2008
Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenes
Paul D Cotter, Lorraine A Draper, Elaine M Lawton, et al.
Current Opinion in Biotechnology
|
November 21, 2017
Identification of probiotic effector molecules: present state and future perspectives
Sarah Lebeer, Peter A Bron, Maria L Marco, et al.
World Journal of Gastrointestinal Pathophysiology
|
September 20, 2023
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against <i>Clostridioides difficile</i> infection challenge <i>in vivo</i>
Christopher K Murphy, Michelle M O'Donnell, James W Hegarty, et al.
Frontiers in Microbiology
|
October 12, 2017
Development of a Click Beetle Luciferase Reporter System for Enhanced Bioluminescence Imaging of <i>Listeria monocytogenes</i>: Analysis in Cell Culture and Murine Infection Models
Sadeeq Ur Rahman, Michael Stanton, Pat G Casey, et al.
The Journal of Dairy Research
|
May 19, 2009
Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1beta and IL-8 gene expression
Christine Beecher, Mairéad Daly, Donagh P Berry, et al.
Radiation Oncology (London, England)
|
July 18, 2018
High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events
Kara D Romano, Colin Hill, Daniel M Trifiletti, et al.
The British Journal of Nutrition
|
July 9, 2011
Probiotic and prebiotic claims in Europe: seeking a clear roadmap
Francisco Guarner, Mary Ellen Sanders, Glenn Gibson, et al.
Current Opinion in Biotechnology
|
October 9, 2018
Understanding mode of action can drive the translational pipeline towards more reliable health benefits for probiotics
Michiel Kleerebezem, Sylvie Binda, Peter A Bron, et al.
Gut Microbes
|
March 30, 2023
Temperate bacteriophages infecting the mucin-degrading bacterium <i>Ruminococcus gnavus</i> from the human gut
Colin Buttimer, Ekaterina V Khokhlova, Lisa Stein, et al.
Applied Microbiology and Biotechnology
|
February 26, 2026
Evaluation of the delivery of an anti-Listeria endolysin via CRISPR-Cas9 engineered probiotic Saccharomyces boulardii
David Sáez Moreno, João Paulo Carvalho, Ellen Murray, et al.
Page
of 55